Intravenous ribavirin for hantavirus pulmonary syndrome: Safety and tolerance during 1 year of open-label experience

Antiviral Therapy

Volumn 4, Issue 4, 1999, Pages 211-219

  Chapman, Louisa E ^a   Mertz, Gregory J ^b   Peters, Clarence J ^a   Jolson, Heidi M ^c   Khan, Ali S ^a   Ksiazek, Thomas G ^a   Koster, Frederick T ^b   Baum, Kenneth F ^d   Rollin, Pierre E ^a   Pavia, Andrew T ^e   Holman, Robert C ^a   Christenson, John C ^e   Rubin, Phillip J ^f   Behrman, Rachel E ^c   Wilson Bell, Linda J ^a   Simpson, Gary L ^g   Sadek, Ramses F ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^d UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^f Infectious Diseases Consultants Ltd   (United States)

^g NEW MEXICO DEPARTMENT OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; RIBAVIRIN;

ADULT; ANEMIA; ARTICLE; BLOOD TRANSFUSION; DIAGNOSTIC TEST; DRUG EFFICACY; DRUG SAFETY; FEMALE; HANTAVIRUS PULMONARY SYNDROME; HOSPITALIZATION; HUMAN; HYPERAMYLASEMIA; HYPERBILIRUBINEMIA; MAJOR CLINICAL STUDY; MALE; PANCREATITIS; PRIORITY JOURNAL; RIGOR; SIDE EFFECT; SURVIVAL RATE; TIME; TREATMENT OUTCOME; UNITED STATES;

ADULT; FEMALE; HANTAVIRUS PULMONARY SYNDROME; HUMANS; INFUSIONS, INTRAVENOUS; MALE; RIBAVIRIN; SELECTION BIAS; UNITED STATES;

EID: 17544365081     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Ksiazek TG, Peters CJ, Rollin PE, Zaki S, Nichol S, Spiropoulou C, Morzunov S, Feldmann H, Sanchez A, Khan AS, Mahy BWJ, Wachsmuth K & Butler JC. Identification of a new North American hantavirus that causes acute pulmonary insufficiency. American Journal of Tropical Medicine & Hygiene 1995; 52:117-123.
2. Duchin JS, Koster FT, Peters CJ, Simpson GL, Tempest B, Zaki SR, Ksiazek TG, Rollin PE, Nichol S, Umland ET, Moolenaar RL, Reef SE, Nolte KB, Gallaher MM, Butler JC, Breiman RF & the Hantavirus Study Group. Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. New England Journal of Medicine 1994; 330:949-955.
3. Nichol ST, Spiropoulou CF, Morzunov S, Rollin PE, Ksiazek TG, Feldman H, Sanchez A, Childs J, Zaki S & Peters CJ. Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness. Science 1993; 262:914-917.
4. Spiropoulou CF, Morzunov S, Feldmann H, Sanchez A, Peters CJ & Nichol ST. Genome structure and variability of a virus causing hantavirus pulmonary syndrome. Virology 1994; 200:715-723.
5. Zaki SR, Greer PW, Coffield LM, Goldsmith CS, Nolte KB, Foucar K, Feddersen RM, Zumwalt RE, Miller GL, Khan AS, Rollin PE, Ksiazek TG, Nichol ST, Mahy BWJ & Peters CJ. Hantavirus pulmonary syndrome. Pathogenesis of an emerging infectious disease. American Journal of Pathology 1995; 146:552-579.